Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.

Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, Witzig TE, Micallef IN, O'Neill BP.

Cancer. 2004 Jun 1;100(11):2403-7.

2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
3.

Primary lymphoma of peripheral nerve: report of four cases.

Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL.

Am J Surg Pathol. 2000 Sep;24(9):1257-65.

PMID:
10976700
4.

Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).

Todeschini G, Tecchio C, Pasini F, Benedetti F, Cantini M, Crippa C, Draisci M, Pizzolo G.

Cancer. 2005 Aug 1;104(3):555-60.

5.

[Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells].

Ptushkin VV, Chimishkian KL, Zhukov NV, Osmanov DSh, Andreeva LIu, Tupitsyn NN, Larionova VB, Mkheidze DM, Poddubnaia NV.

Ter Arkh. 2003;75(1):65-8. Russian.

PMID:
12652962
6.

Primary non-Hodgkin's lymphoma of the sciatic nerve followed by localization in the central nervous system: case report and review of the literature.

Roncaroli F, Poppi M, Riccioni L, Frank F.

Neurosurgery. 1997 Mar;40(3):618-21; discussion 621-2. Review.

PMID:
9055305
7.

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.

Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM.

J Clin Oncol. 2003 Nov 15;21(22):4151-6.

PMID:
14615443
8.
9.

[Primary central nervous system lymphoma--a report of 32 cases with literature review].

Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):476-80. Review. Chinese.

PMID:
16613684
10.

Neurolymphomatosis.

Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH.

Neuro Oncol. 2003 Apr;5(2):104-15.

11.

[Autologous peripheral blood stem cell transplantation in the treatment of patients with primary large mediastinal B-cell lymphoma].

He XH, Shi YK, Han XH, Zhou AP, Zhou SY, Liu P, Yang JL, Feng FY.

Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):592-5. Chinese.

PMID:
14690571
12.

Solitary T-cell lymphoma of the sciatic nerve: case report.

Kanamori M, Matsui H, Yudoh K.

Neurosurgery. 1995 Jun;36(6):1203-5.

PMID:
7644005
13.

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.

Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B; German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL).

Cancer. 2006 Jan 1;106(1):136-45.

14.

[Effective combined modality therapy for a patient with primary adrenal lymphoma].

Shirao S, Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Konuma Y, Hirayama Y, Kohda K.

Rinsho Ketsueki. 2006 Mar;47(3):204-9. Japanese.

PMID:
16629485
15.
16.

High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.

Illerhaus G, Müller F, Feuerhake F, Schäfer AO, Ostertag C, Finke J.

Haematologica. 2008 Jan;93(1):147-8. doi: 10.3324/haematol.11771.

17.

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.

J Clin Oncol. 2006 Aug 20;24(24):3865-70. Epub 2006 Jul 24.

PMID:
16864853
18.

Primary sciatic nerve lymphoma: a case report and review of the literature.

Descamps MJ, Barrett L, Groves M, Yung L, Birch R, Murray NM, Linch DC, Lunn MP, Reilly MM.

J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1087-9. Review.

19.

Primary cauda equina lymphoma treated with high-dose methotrexate.

Iwasaki M, Hida K, Yano S, Aoyama T, Kaneko S, Iwasaki Y.

Neurol Med Chir (Tokyo). 2012;52(9):679-83.

20.

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.

Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T.

Bone Marrow Transplant. 2006 Sep;38(6):417-20.

PMID:
16951691

Supplemental Content

Support Center